Services on Demand
Journal
Article
Indicators
Cited by SciELO
Access statistics
Related links
Cited by Google
Similars in SciELO
Similars in Google
Share
Revista Colombiana de Cardiología
Print version ISSN 0120-5633
Abstract
GOMEZ-MESA, Juan E. and GRUPO INVESTIGADOR RECOLFACA et al. Colombian registry of heart failure (RECOLFACA): results. Rev. Colomb. Cardiol. [online]. 2021, vol.28, n.4, pp.334-344. Epub Oct 18, 2021. ISSN 0120-5633. https://doi.org/10.24875/rccar.m21000063.
Introduction:
Heart failure (HF) is a public health problem worldwide. In Latin America, incidence is 199 / 100,000 person-year and prevalence is ≈1%. In Colombia, few studies have described the sociodemographic and clinical behavior of patients with acutely decompensated HF (ADHF) and chronic HF (CHF).
Method:
A multicenter registry was implemented to identify characteristics that can help in the planning and development of secondary prevention and treatment strategies for this population.
Results:
2528 patients were included. 57.59% men, average age 69 years. The main comorbidity was arterial hypertension (72.04%). The main causes of HF decompensation were disease progression (35.00%) and insufficient treatment (19.09%). The most frequent etiology was ischemic (43.99%). At the time of admission, 86.95% of patients received beta-blocker, 67.25% received diuretics, 55.66% received MRA, 42.41% received ARB-II, 33.66% received ACEI, and 9.73% received ARNI.
Conclusions:
Patients with HF in Colombia are similar to those described by other HF registries in the western world, highlighting the use of evidence-based therapies. A lower proportion of atrial fibrillation was documented, with a higher frequency of moderate-severe systolic dysfunction and an apparent suboptimal use of implantable devices.
Keywords : Heart failure; Hospitalization; Mortality; Treatment; Devices.